Targeting kinases that regulate programmed cell death: a new therapeutic strategy for breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Cell Death Research

Background:

• Breast cancer is a leading cause of cancer deaths in women, often due to diagnostic delays and treatment limitations.
• There is a critical need for novel therapeutic targets and strategies to improve breast cancer treatment outcomes.
• Understanding molecular mechanisms of programmed cell death offers new therapeutic avenues.

Purpose of the Study:

• To review recent advancements in targeting kinase-regulated programmed cell death for breast cancer treatment.
• To summarize key kinases involved in various programmed cell death pathways in breast cancer.
• To discuss strategies for modulating these kinases therapeutically.

Main Methods:

• Literature review of recent research on kinase-regulated programmed cell death in breast cancer.
• Analysis of the roles of specific kinases in breast cancer onset and progression.
• Examination of pharmacological interventions targeting these kinases.

Main Results:

• Kinase-regulated programmed cell death pathways (apoptosis, pyroptosis, autophagy, necroptosis, ferroptosis) are crucial in breast cancer.
• Specific kinases play significant roles in breast cancer development and progression.
• Pharmacological modulation of these kinases presents a viable therapeutic strategy.

Conclusions:

• Targeting kinase-regulated programmed cell death is a promising approach for novel breast cancer therapies.
• Identifying and modulating key kinases can improve treatment efficacy and patient outcomes.
• Further research into these pathways will advance breast cancer treatment strategies.